Nationwide Fund Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-41,302
Closed -$1.29M 1008
2017
Q3
$1.29M Buy
41,302
+6,947
+20% +$132K 0.01% 1651
2017
Q2
$590K Sell
34,355
-1,775
-5% -$30.3K ﹤0.01% 2092
2017
Q1
$633K Sell
36,130
-2,524
-7% -$38.9K ﹤0.01% 2032
2016
Q4
$511K Sell
38,654
-2,222
-5% -$30.3K ﹤0.01% 2166
2016
Q3
$594K Hold
40,876
﹤0.01% 2090
2016
Q2
$403K Buy
40,876
+1,367
+3% +$16K ﹤0.01% 2258
2016
Q1
$518K Sell
39,509
-1,194
-3% -$15.7K ﹤0.01% 2078
2015
Q4
$739K Buy
40,703
+883
+2% +$15.6K ﹤0.01% 1885
2015
Q3
$739K Hold
39,820
﹤0.01% 1880
2015
Q2
$972K Buy
39,820
+3,564
+10% +$80.9K ﹤0.01% 1874
2015
Q1
$754K Sell
36,256
-1,537
-4% -$27.1K ﹤0.01% 2034
2014
Q4
$585K Sell
37,793
-116
-0.3% -$1.65K ﹤0.01% 2092
2014
Q3
$495K Buy
37,909
+7,821
+26% +$118K ﹤0.01% 2222
2014
Q2
$601K Sell
30,088
-177,160
-85% -$2.62M ﹤0.01% 2160
2014
Q1
$3.95M Buy
207,248
+3,800
+2% +$72.2K 0.02% 996
2013
Q4
$3.46M Buy
203,448
+175,924
+639% +$2.69M 0.01% 1156
2013
Q3
$430K Buy
27,524
+18,467
+204% +$235K ﹤0.01% 2302
2013
Q2
$108K Buy
+9,057
New +$92.6K ﹤0.01% 2772

Other funds holding INSM

Nationwide Fund Advisors's INSM Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Insmed (INSM) in Q4 2017, closing a stake of 41,302 shares — an estimated $1.29M sold.

Nationwide Fund Advisors first reported a position in INSM in Q2 2013 and held it in 18 quarters. The position peaked at $3.95M in Q1 2014. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 41,302 Insmed shares in Q4 2017, an estimated $1.29M.
  • Nationwide Fund Advisors first reported a position in Insmed in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Insmed position peaked at $3.95M in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.